Aspire-Lakewood Holdings, Inc.
ASBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire-Lakewood Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.
Other share classesASBPW
Q4 2023 vs. Q3 2023
How the institutions holding Aspire-Lakewood Holdings, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 21 | 21 | 0 |
| Shares | 1.72M | 1.72M | +833 (0.0%) |
| Value | $18.2M | $17.9M | −$289.2K (−1.6%) |
New holders (3)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Glazer Capital, LLC | 30,639 | $334.0K | 0.03% |
| Tuttle Tactical Management | 17,000 | $185.1K | 1.29% |
| BlackRock Inc. | 300 | $3.27K | 0.00% |
Sold out (3)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Mizuho Securities USA LLC | 35,000 | $376.3K |
| UBS Group AG | 60 | $650 |
| Tower Research Capital LLC (TRC) | 8 | $87 |